What will 2020 bring for medicine and science? We asked 16 leaders for predictions
Last year, when we asked science and health care soothsayers to peak ahead to 2019, they told us that methamphetamine use would rise (it did), tumor organoids would near clinical use for personalizing cancer treatment and better targeting clinical trials (that’s happening), and price transparency wouldn’t bring lower health spending (that’s true, too). But nobody predicted the outbreak of lung injuries tied to vaping, the failure and attempted resurrection of Biogen’s Alzheimer’s drug aducanumab, or the restoration of cellular functions in pig brains after death.
We’re back with a new set of predictions for 2020. Let’s see how our experts do this time.
